Welcome to the HCP Toolkits
This section provides HCP tools for checkpoint inhibitors used in oncology as well as the intralesional therapy used in melanoma. Each tool is available as a PDF which can be viewed online and is optimized for easy printing.
For each therapy, the tool provides an overview of drug dosing and administration, side effects, clinical pearls, Q & A, patient and HCP resources, and specific side-effect management content. Each tool also contains a link to corresponding printable patient action plans to share with patients.
The toolkits link away to the Care Step Pathways (CSPs), innovative yet practical resources developed by the members of the IO Essentials faculty to address notable toxicities associated with immunotherapies. The Care Step Pathways are featured in their own tab in case you would like to review/print out individual CSPs.
We hope that you find these tools useful in your efforts to optimize care for your patients with cancer receiving immune checkpoint inhibitors or intralesional therapies.
List of Toolkits
- IMLYGIC® (talimogene laherparepvec; T-VEC)
- KEYTRUDA® (pembrolizumab)
- OPDIVO® (nivolumab)
- OPDIVO® (nivolumab)/YERVOY® (ipilimumab)
- YERVOY® (ipilimumab)